These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32150208)

  • 1. Clinically Meaningful Change for Physical Performance: Perspectives of the ICFSR Task Force.
    Guralnik J; Bandeen-Roche K; Bhasin SAR; Eremenco S; Landi F; Muscedere J; Perera S; Reginster JY; Woodhouse L; Vellas B
    J Frailty Aging; 2020; 9(1):9-13. PubMed ID: 32150208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing Drug Trials for Frailty: ICFSR Task Force 2018.
    Pahor M; Kritchevsky SB; Waters DL; Villareal DT; Morley J; Hare JM; Vellas B
    J Frailty Aging; 2018; 7(3):150-154. PubMed ID: 30095144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ICFSR Task Force Perspective on Biomarkers for Sarcopenia and Frailty.
    Rodriguez-Mañas L; Araujo de Carvalho I; Bhasin S; Bischoff-Ferrari HA; Cesari M; Evans W; Hare JM; Pahor M; Parini A; Rolland Y; Fielding RA; Walston J; Vellas B
    J Frailty Aging; 2020; 9(1):4-8. PubMed ID: 32150207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional Intervention in Sarcopenia: Report from the International Conference on Frailty and Sarcopenia Research Task Force.
    Landi F; Sieber C; Fielding RA; Rolland Y; Guralnik J
    J Frailty Aging; 2018; 7(4):247-252. PubMed ID: 30298173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcopenia Trials in Specific Diseases: Report by the International Conference on Frailty and Sarcopenia Research Task Force.
    Vellas B; Fielding R; Bhasin S; Cerreta F; Goodpaster B; Guralnik JM; Kritchevsky S; Legrand V; Forkin C; Magaziner J; Morley JE; Rodriguez-Manas L; Roubenoff R; Studenski S; Villareal DT; Cesari M;
    J Frailty Aging; 2016; 5(4):194-200. PubMed ID: 27883164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in the Development of Drugs for Sarcopenia and Frailty - Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force.
    Cesari M; Bernabei R; Vellas B; Fielding RA; Rooks D; Azzolino D; Mariani J; Oliva AA; Bhasin S; Rolland Y
    J Frailty Aging; 2022; 11(2):135-142. PubMed ID: 35441189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PHARMACOLOGICAL INTERVENTIONS IN FRAILTY AND SARCOPENIA: REPORT BY THE INTERNATIONAL CONFERENCE ON FRAILTY AND SARCOPENIA RESEARCH TASK FORCE.
    Cesari M; Fielding R; Bénichou O; Bernabei R; Bhasin S; Guralnik JM; Jette A; Landi F; Pahor M; Rodriguez-Manas L; Rolland Y; Roubenoff R; Sinclair AJ; Studenski S; Travison T; Vellas B
    J Frailty Aging; 2015; 4(3):114-120. PubMed ID: 26366378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplement: 9th International Conference on Frailty and Sarcopenia Research (ICFSR), Symposia - Conferences - Oral Communications, February 20-22, 2019, Miami - USA.
    J Frailty Aging; 2019; 8(1):S1-S25. PubMed ID: 30734833
    [No Abstract]   [Full Text] [Related]  

  • 9. Implications of ICD-10 for Sarcopenia Clinical Practice and Clinical Trials: Report by the International Conference on Frailty and Sarcopenia Research Task Force.
    Vellas B; Fielding RA; Bens C; Bernabei R; Cawthon PM; Cederholm T; Cruz-Jentoft AJ; Del Signore S; Donahue S; Morley J; Pahor M; Reginster JY; Rodriguez Mañas L; Rolland Y; Roubenoff R; Sinclair A; Cesari M
    J Frailty Aging; 2018; 7(1):2-9. PubMed ID: 29412436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resilience: Biological Basis and Clinical Significance - A Perspective Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force.
    Cesari M; Azzolino D; LeBrasseur NK; Whitson H; Rooks D; Sourdet S; Angioni D; Fielding RA; Vellas B; Rolland Y
    J Frailty Aging; 2022; 11(4):342-347. PubMed ID: 36346720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis in Frail Older Adults: Recommendations for Research from the ICFSR Task Force 2020.
    Rolland Y; Cesari M; Fielding RA; Reginster JY; Vellas B; Cruz-Jentoft AJ
    J Frailty Aging; 2021; 10(2):168-175. PubMed ID: 33575707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The feasibility of assessing frailty and sarcopenia in hospitalised older people: a comparison of commonly used tools.
    Ibrahim K; Howson FFA; Culliford DJ; Sayer AA; Roberts HC
    BMC Geriatr; 2019 Feb; 19(1):42. PubMed ID: 30770722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management.
    Dent E; Morley JE; Cruz-Jentoft AJ; Woodhouse L; Rodríguez-Mañas L; Fried LP; Woo J; Aprahamian I; Sanford A; Lundy J; Landi F; Beilby J; Martin FC; Bauer JM; Ferrucci L; Merchant RA; Dong B; Arai H; Hoogendijk EO; Won CW; Abbatecola A; Cederholm T; Strandberg T; Gutiérrez Robledo LM; Flicker L; Bhasin S; Aubertin-Leheudre M; Bischoff-Ferrari HA; Guralnik JM; Muscedere J; Pahor M; Ruiz J; Negm AM; Reginster JY; Waters DL; Vellas B
    J Nutr Health Aging; 2019; 23(9):771-787. PubMed ID: 31641726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US Task Force recommendations.
    Vellas B; Pahor M; Manini T; Rooks D; Guralnik JM; Morley J; Studenski S; Evans W; Asbrand C; Fariello R; Pereira S; Rolland Y; Abellan van Kan G; Cesari M; Chumlea WC; Fielding R
    J Nutr Health Aging; 2013 Jul; 17(7):612-8. PubMed ID: 23933872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DESIGNING DRUG TRIALS FOR SARCOPENIA IN OLDER ADULTS WITH HIP FRACTURE - A TASK FORCE FROM THE INTERNATIONAL CONFERENCE ONFRAILTY AND SARCOPENIA RESEARCH (ICFSR).
    Vellas B; Fielding R; Miller R; Rolland Y; Bhasin S; Magaziner J; Bischoff-Ferrari H
    J Frailty Aging; 2014; 3(4):199-204. PubMed ID: 26380231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carla Task Force on Sarcopenia: propositions for clinical trials.
    Abellan van Kan G; André E; Bischoff Ferrari HA; Boirie Y; Onder G; Pahor M; Ritz P; Rolland Y; Sampaio C; Studenski S; Visser M; Vellas B
    J Nutr Health Aging; 2009 Oct; 13(8):700-7. PubMed ID: 19657553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Instruments to assess sarcopenia and physical frailty in older people living in a community (care) setting: similarities and discrepancies.
    Mijnarends DM; Schols JM; Meijers JM; Tan FE; Verlaan S; Luiking YC; Morley JE; Halfens RJ
    J Am Med Dir Assoc; 2015 Apr; 16(4):301-8. PubMed ID: 25530211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia.
    Ticinesi A; Nouvenne A; Cerundolo N; Catania P; Prati B; Tana C; Meschi T
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31319564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study.
    Kim S; Kim M; Won CW
    J Am Med Dir Assoc; 2018 Jan; 19(1):40-45.e1. PubMed ID: 28843526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common Ground? The Concordance of Sarcopenia and Frailty Definitions.
    Reijnierse EM; Trappenburg MC; Blauw GJ; Verlaan S; de van der Schueren MA; Meskers CG; Maier AB
    J Am Med Dir Assoc; 2016 Apr; 17(4):371.e7-12. PubMed ID: 26922807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.